Annual Accounts Receivable
$5.78 M
-$7.31 M-55.85%
31 December 2023
Summary:
MaxCyte annual accounts receivable is currently $5.78 million, with the most recent change of -$7.31 million (-55.85%) on 31 December 2023. During the last 3 years, it has fallen by -$1.10 million (-15.98%). MXCT annual accounts receivable is now -55.85% below its all-time high of $13.09 million, reached on 31 December 2022.MXCT Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$4.56 M
-$21.00 K-0.46%
30 September 2024
Summary:
MaxCyte quarterly accounts receivable is currently $4.56 million, with the most recent change of -$21.00 thousand (-0.46%) on 30 September 2024. Over the past year, it has dropped by -$1.22 million (-21.08%). MXCT quarterly accounts receivable is now -65.16% below its all-time high of $13.09 million, reached on 31 December 2022.MXCT Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MXCT Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -21.1% |
| 3 y3 years | -16.0% | -33.7% |
| 5 y5 years | +78.1% | +40.5% |
MXCT Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -55.9% | at low | -65.2% | at low |
| 5 y | 5 years | -55.9% | +78.1% | -65.2% | +40.5% |
| alltime | all time | -55.9% | +829.4% | -65.2% | +269.9% |
MaxCyte Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $4.56 M(-0.5%) |
| June 2024 | - | $4.58 M(-23.5%) |
| Mar 2024 | - | $5.99 M(+3.7%) |
| Dec 2023 | $5.78 M(-55.8%) | $5.78 M(-29.2%) |
| Sept 2023 | - | $8.17 M(+7.3%) |
| June 2023 | - | $7.61 M(-18.1%) |
| Mar 2023 | - | $9.29 M(-29.0%) |
| Dec 2022 | $13.09 M(+90.3%) | $13.09 M(+59.4%) |
| Sept 2022 | - | $8.21 M(+3.8%) |
| June 2022 | - | $7.91 M(-26.4%) |
| Mar 2022 | - | $10.75 M(+56.3%) |
| Dec 2021 | $6.88 M(+33.0%) | $6.88 M(+15.4%) |
| Sept 2021 | - | $5.96 M(+4.2%) |
| June 2021 | - | $5.72 M(+10.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $5.17 M(+59.4%) | $5.17 M(+38.0%) |
| June 2020 | - | $3.75 M(+15.5%) |
| Dec 2019 | $3.24 M(-33.8%) | $3.24 M(+16.2%) |
| June 2019 | - | $2.79 M(-43.1%) |
| Dec 2018 | $4.90 M(+53.5%) | $4.90 M(+30.3%) |
| June 2018 | - | $3.76 M(+17.7%) |
| Dec 2017 | $3.20 M(+32.6%) | $3.20 M(-14.6%) |
| June 2017 | - | $3.74 M(+55.2%) |
| Dec 2016 | $2.41 M(+66.1%) | $2.41 M(+8.2%) |
| June 2016 | - | $2.23 M(+53.5%) |
| Dec 2015 | $1.45 M(+3.5%) | $1.45 M(+17.7%) |
| June 2015 | - | $1.23 M(-12.1%) |
| Dec 2014 | $1.40 M(+82.8%) | $1.40 M |
| Dec 2013 | $767.10 K(+23.4%) | - |
| Dec 2012 | $621.70 K | - |
FAQ
- What is MaxCyte annual accounts receivable?
- What is the all time high annual accounts receivable for MaxCyte?
- What is MaxCyte quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for MaxCyte?
- What is MaxCyte quarterly accounts receivable year-on-year change?
What is MaxCyte annual accounts receivable?
The current annual accounts receivable of MXCT is $5.78 M
What is the all time high annual accounts receivable for MaxCyte?
MaxCyte all-time high annual accounts receivable is $13.09 M
What is MaxCyte quarterly accounts receivable?
The current quarterly accounts receivable of MXCT is $4.56 M
What is the all time high quarterly accounts receivable for MaxCyte?
MaxCyte all-time high quarterly accounts receivable is $13.09 M
What is MaxCyte quarterly accounts receivable year-on-year change?
Over the past year, MXCT quarterly accounts receivable has changed by -$1.22 M (-21.08%)